Sonnet BioTherapeutics Holdings, Inc. (SONN)

Revenue by Segment

Financials in millions USD. Fiscal year is October - September.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Immuno-oncology Treatments	18.63K
Immuno-oncology Treatments Growth	-87.40%

Revenue by Geography

Financials in millions USD. Fiscal year is October - September.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
United States	18.63K
United States Growth	-87.40%